Sales enablement: a case study playbook for PE-backed portfolio companies in the Middle East
The anatomy of a sales enablement engagement that worked — what we tried, what we killed, and what we would repeat. Written for operating partners and portfolio CEOs inside private equity in the Middle East.
This edition of the Growth Broker playbook is written for operating partners and portfolio CEOs inside private equity operating in the Middle East. In this market, Middle Eastern buyers reward in-person credibility, sovereign fit, and patient sequencing, so the way you install sales enablement has to be shaped to that reality from day one.
Names removed, numbers preserved. This is a real sales enablement engagement, reproduced as a playbook. Client had product-market fit, a rev team of eleven, and a stalled pipeline.
Week one: diagnosis. The stated problem was "not enough leads". The actual problem was content libraries no one opens, which had been masked by inbound velocity that peaked two quarters earlier.
Weeks two to three: rebuild the target list from scratch and re-cut the trigger. Sales enablement works when reps waste 25% of the week hunting for content; the client had drifted away from that first principle.
Inside PE-backed portfolio companies, the binding constraint is almost always predictable execution against a hold-period thesis, and in the Middle East it is compounded by the fact that senior-relationship access, not product is what actually gates growth. Sales enablement is only useful here when it is pointed at both constraints at once.
Weeks four to six: live at 20% of previous volume, quality bar raised. Ramp time for new reps to first closed-won moved every week, though absolute numbers stayed modest.
Weeks seven to twelve: ramp. By week ten the number was ahead of the pre-stall baseline. By week twelve it was 40% ahead. Cost per outcome was roughly halved.
What we would repeat: the diagnosis step, the quality bar, and the weekly review. What we would kill sooner: two tools we bought in month one that added noise instead of leverage.
The client's own summary at the end of quarter one: "we thought we needed more of everything; we actually needed less of the wrong things." That is usually the lesson.
Concretely for PE-backed portfolio companies in the Middle East: the portfolio companies that install this hit the next value-creation milestone on schedule, and one sovereign or family-office win in the Middle East justifies a full year of program spend. That is the reason it is worth installing sales enablement deliberately for this market rather than importing a playbook designed for somewhere else.
Frequently asked questions
Sales · PE-backed · Middle East — answered
- Does sales enablement work for PE-backed portfolio companies in the Middle East?
- Yes — provided it is pointed at predictable execution against a hold-period thesis and adapted to the fact that in the Middle East, Middle Eastern buyers reward in-person credibility, sovereign fit, and patient sequencing. The portfolio companies that install this hit the next value-creation milestone on schedule.
- How long until the case study company saw results?
- The metric moved in week four; the absolute number caught up around week ten.
- What did the client stop doing?
- Running old tools on autopilot and confusing volume with progress.
- What did the client keep doing?
- The Monday plan, the Friday review, and the weekly ramp time for new reps to first closed-won readout.
- Is this case study repeatable?
- The process is repeatable; the numbers depend on category, team, and starting point.
- What is the Middle East-specific pitfall when running sales enablement for PE-backed?
- Importing a playbook that was built for another market. In the Middle East, Middle Eastern buyers reward in-person credibility, sovereign fit, and patient sequencing — the install has to reflect that.
Growth Broker editorial
Filed under sales · pe-backed · middle east